Biomedical Odyssey

Life at the Johns Hopkins School of Medicine

petry dish in the lab

Uncovering How a Diabetes Drug Slows Cancer Growth

February 3, 2017

What do a relatively unknown gene, a well-known signaling pathway and nuclear transport have in common? They’re all part of how diabetes and cancer drug metformin works. Metformin is a widely used type 2 diabetes drug that lowers glucose levels and sensitizes cells to insulin. Metformin’s mechanism has been long sought after, and studies into […]

Dawn Hayward ⋅ Perspectives in Research cancer drugs, diabetes ⋅

Clinical trial to target cancer drugs to gene mutations for individualized therapy

July 20, 2015

Imagine a scenario where a patient comes into the clinic with a suspected cancer. The clinician not only confirms that the patient does indeed have cancer, but also identifies a specific gene abnormality that is driving the tumor. Without hesitating, the doctor prescribes a cancer drug that specifically targets the gene mutation responsible for the […]

Paul Sirajuddin ⋅ Perspectives in Research American Society of Clinical Oncology, Cancer, cancer drugs, dna sequencing, gene mutation, MATCH, National Cancer Institute, pharmaceuticals ⋅

Cancer Immunotherapy: The Next Breakthrough Gains Footing

March 5, 2015

What do faulty brakes on a car and cancer cells have in common? For one, cancer cells have found ways to evade checkpoints that the body’s cells use as brakes to stop them from dividing out of control. By this same analogy, the accelerator in a cancer cell is always pushed to the floor, and […]

Paul Sirajuddin ⋅ Perspectives in Research cancer drugs, immunotherapy ⋅

Subscribe to the Blog

Introduction

  • About This Blog
  • Meet the Authors
  • Do You Want to Write for Us?

Blog Categories

  • A Day in the Life
  • Events and Happenings
  • Honor Roll
  • Perspectives in Research

More About the School of Medicine

  • Johns Hopkins University School of Medicine
  • Life at Hopkins
  • Training at Johns Hopkins School of Medicine

Archives